Acoustic startle

BEHAVIORAL3 trials

Sponsors

National Institute of Mental Health (NIMH), Emory University, Lykos Therapeutics

Conditions

Anxiety DisordersFearMajor Depressive DisorderStartle Response

Phase 1

Evaluation of MDMA on Startle Response

CompletedNCT03181763

Lykos TherapeuticsStartle Response

Start: 2017-03-14End: 2020-08-01Updated: 2025-03-04

Unknown Phase

Brain Imaging Changes in Fear and Anxiety

CompletedNCT00047853

National Institute of Mental Health (NIMH)Anxiety Disorders, Fear

Start: 2002-11-04End: 2022-07-28Updated: 2024-03-12

Characterizing Psychological Consequences of Childhood Trauma

CompletedNCT00209105

Emory UniversityMajor Depressive Disorder

Start: 2005-01-31End: 2011-03-31Updated: 2013-11-13

Related Papers

A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults

Journal of Psychopharmacology2022-02-1545 citations